Measuring hsCRP--an important part of a comprehensive risk profile or a clinically redundant practice?

by James P McCormack, G Michael Allan
Published 2010-02-01

Higher versus lower doses of ACE inhibitors, angiotensin-2 receptor blockers and beta-blockers in heart failure with reduced ejection fraction: Systematic review and meta-analysis.

by Ricky D Turgeon, Michael R Kolber, Peter Loewen, Ursula Ellis, James P McCormack
Published 2019-01-01